Eric Hidari
Impact in
-
- Alzheimer's disease research and treatments
Papers in
-
- Alzheimer's disease research and treatments 9
-
- Parkinson's Disease Mechanisms and Treatments 4
- Botulinum Toxin and Related Neurological Disorders 2
- Neurological Disease Mechanisms and Treatments 1
- Co-authors
- David A. Klenerman (7 shared papers)Georg Meisl (4 shared papers)Jason C. Sang (2 shared papers)James Benedict Rowe (2 shared papers)Timothy Rittman (2 shared papers)Rohan T. Ranasinghe (3 shared papers)Maria Grazia Spillantini (2 shared papers)Keith A. Johnson (1 shared paper)
- Journals
- Nature Communications (2 papers)ChemBioChem (1 paper)Cell Reports Methods (1 paper)Science Advances (1 paper)Acta Neuropathologica Communications (1 paper)
- Partner nations
- United KingdomUnited StatesPoland
In The Last Decade
Eric Hidari
9 papers receiving 295 citations
Peers
Comparison fields: 5 of 60
- Physiology 181
- Structural Biology 10
- Neurology 48
- Biological Psychiatry 12
- Biophysics 26
Countries citing papers authored by Eric Hidari
This map shows the geographic impact of Eric Hidari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Hidari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Hidari more than expected).
Fields of papers citing papers by Eric Hidari
This network shows the impact of papers produced by Eric Hidari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Hidari. The network helps show where Eric Hidari may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric Hidari, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 96 | |
| 2 | 2022 | 63 | |
| 3 | 2021 | 38 | |
| 4 | 2024 | 37 | |
| 5 | 2023 | 23 | |
| 6 | 2021 | 16 | |
| 7 | 2021 | 12 | |
| 8 | 2023 | 8 | |
| 9 | 2023 | 8 |
About Eric Hidari
Eric Hidari is a scholar working on Physiology, Neurology, Pharmacology, Molecular Biology and Biophysics, having authored 9 papers that have together received 301 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (9 papers), Parkinson's Disease Mechanisms and Treatments (4 papers), Botulinum Toxin and Related Neurological Disorders (2 papers), Cholinesterase and Neurodegenerative Diseases (2 papers), S100 Proteins and Annexins (1 paper), Computational Drug Discovery Methods (1 paper), Neurological Disease Mechanisms and Treatments (1 paper) and RNA regulation and disease (1 paper). The work is most often cited by research in Physiology (181 citations), Structural Biology (10 citations), Neurology (48 citations), Biological Psychiatry (12 citations) and Biophysics (26 citations). Eric Hidari has collaborated with scholars based in United Kingdom, United States and Poland. Frequent co-authors include David A. Klenerman, Georg Meisl, Jason C. Sang, James Benedict Rowe, Timothy Rittman, Rohan T. Ranasinghe, Maria Grazia Spillantini, Keith A. Johnson, Karen Duff and Justin S. Sanchez. Their work appears in journals such as Nature Communications, ChemBioChem, Cell Reports Methods, Science Advances and Acta Neuropathologica Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.